Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,177.20
(
1.66%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
96.99
(
-4.14%
)
Bitcoin
75,889.67
(
-1.79%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

patientsdeservebest

Send PM Follow Ignore
Followers 9
Posts 222
Boards Moderated 0
Alias Born 09/26/2012

patientsdeservebest

Re: biopharm post# 152695

Friday, 12/20/2013 10:43:26 AM

Friday, December 20, 2013 10:43:26 AM

Post# of 347009
Steve King has neither a PhD nor an MD.
He does have a failed phase II and a product Cotara that is doing virtually nothing except losing patent life if it even has any left at this point.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote